IL1RL2 and generalized pustular psoriasis: Notably, elevated IL-36 cytokine pathway activity is implicated in the pathogenesis of generalized pustular psoriasis (GPP), as up to 1/3 of GPP patients have missense mutations in IL-36RN, which inhibits IL-36 receptor activation [117].